These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 31332077)
1. The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus. Gutiérrez AV; Richard M; Roquet-Banères F; Viljoen A; Kremer L Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332077 [No Abstract] [Full Text] [Related]
2. Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in Richard M; Gutiérrez AV; Viljoen A; Rodriguez-Rincon D; Roquet-Baneres F; Blaise M; Everall I; Parkhill J; Floto RA; Kremer L Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323043 [TBL] [Abstract][Full Text] [Related]
3. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages. Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005 [TBL] [Abstract][Full Text] [Related]
4. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish. Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917 [TBL] [Abstract][Full Text] [Related]
5. Novel Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus. Chen Y; Chen J; Zhang S; Shi W; Zhang W; Zhu M; Zhang Y Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712660 [No Abstract] [Full Text] [Related]
6. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria. Ruth MM; Sangen JJN; Remmers K; Pennings LJ; Svensson E; Aarnoutse RE; Zweijpfenning SMH; Hoefsloot W; Kuipers S; Magis-Escurra C; Wertheim HFL; van Ingen J J Antimicrob Chemother; 2019 Apr; 74(4):935-943. PubMed ID: 30649327 [TBL] [Abstract][Full Text] [Related]
7. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus. Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658 [TBL] [Abstract][Full Text] [Related]
8. Acquired resistance of Mycobacterium tuberculosis to bedaquiline. Andries K; Villellas C; Coeck N; Thys K; Gevers T; Vranckx L; Lounis N; de Jong BC; Koul A PLoS One; 2014; 9(7):e102135. PubMed ID: 25010492 [TBL] [Abstract][Full Text] [Related]
9. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678. Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740 [TBL] [Abstract][Full Text] [Related]
11. Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis. Liu Y; Gao J; Du J; Shu W; Wang L; Wang Y; Xue Z; Li L; Xu S; Pang Y Int J Infect Dis; 2021 Jan; 102():392-396. PubMed ID: 33130209 [TBL] [Abstract][Full Text] [Related]
12. Targeting bedaquiline mycobacterial efflux pump to potentially enhance therapy in Martin A; Bouyakoub Y; Soumillion K; Mantu EON; Colmant A; Rodriguez-Villalobos H Int J Mycobacteriol; 2020; 9(1):71-75. PubMed ID: 32474492 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Nontuberculous Mycobacteria in Nanjing and Zhang R; Luo S; Wang N; Zhang H; Wu X Infect Drug Resist; 2023; 16():2751-2764. PubMed ID: 37180636 [TBL] [Abstract][Full Text] [Related]
15. Investigating the role of Yusuf B; Wang S; Alam MS; Zhang J; Liu Z; Lu Z; Ding J; Chiwala G; Gao Y; Fang C; Khan SA; Tian X; Islam MM; Hameed HMA; Maslov DA; Zhong N; Hu J; Zhang T Microbiol Spectr; 2024 Oct; 12(10):e0397423. PubMed ID: 39162545 [TBL] [Abstract][Full Text] [Related]
16. Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients. Shang Y; Chen S; Shi W; Nie W; Jing W; Huo F; Xue Y; Dong L; Jiang G; Huang H; Chu N J Glob Antimicrob Resist; 2023 Jun; 33():294-300. PubMed ID: 37142094 [TBL] [Abstract][Full Text] [Related]
17. Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis. Xu J; Li D; Shi J; Wang B; Ge F; Guo Z; Mu X; Nuermberger E; Lu Y Antimicrob Agents Chemother; 2023 Jul; 67(7):e0153222. PubMed ID: 37255473 [TBL] [Abstract][Full Text] [Related]
18. Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis. Hartkoorn RC; Uplekar S; Cole ST Antimicrob Agents Chemother; 2014 May; 58(5):2979-81. PubMed ID: 24590481 [TBL] [Abstract][Full Text] [Related]
19. Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384. Halloum I; Viljoen A; Khanna V; Craig D; Bouchier C; Brosch R; Coxon G; Kremer L Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096157 [TBL] [Abstract][Full Text] [Related]
20. Mechanistic and Structural Insights Into the Unique TetR-Dependent Regulation of a Drug Efflux Pump in Richard M; Gutiérrez AV; Viljoen AJ; Ghigo E; Blaise M; Kremer L Front Microbiol; 2018; 9():649. PubMed ID: 29675007 [No Abstract] [Full Text] [Related] [Next] [New Search]